<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>cc981</ui>
   <ji>CCJ</ji>
   <fm>
      <dochead>Meeting abstract</dochead>
      <bibl>
         <title>
            <p>Diabetes mellitus and morbidity and mortality risks after cardiac surgery</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Toh</snm>
               <fnm>K</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Dill-Russell</snm>
               <fnm>PC</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Valencia</snm>
               <fnm>O</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Departments of Anaesthesia and Cardiac Surgery, St George's Hospital, Tooting, London, UK</p>
            </ins>
         </insg>
         <source>Critical Care</source>
         <supplement>
            <title>
               <p>Autumn Scientific Meeting of the Association of Cardiothoracic Anaesthetists</p>
            </title>
            <sponsor>
               <note>Supported by an unrestricted educational grant from Bayer Biological Group</note>
            </sponsor>
            <note>Meeting abstracts</note>
         </supplement>
         <conference>
            <title>
               <p>Autumn Scientific Meeting of the Association of Cardiothoracic Anaesthetists</p>
            </title>
            <location>Windermere, UK</location>
            <date-range>3 November 2000</date-range>
         </conference>
         <issn>1364-8535</issn>
         <pubdate>2001</pubdate>
         <volume>5</volume>
         <issue>Suppl A</issue>
         <fpage>4</fpage>
         <url>http://ccforum.com/content/5/1/046</url>
         <xrefbib>
            <pubid idtype="doi">10.1186/cc981</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>4</day>
               <month>1</month>
               <year>2001</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2000</year>
         <collab>BioMed Central Ltd on behalf of the copyright holder</collab>
      </cpyrt>
   </fm>
   <meta>
      <classifications>
         <classification type="BMC" subtype="old_arx_id">cc-5-1-046-4</classification>
      </classifications>
   </meta>
   <bdy>
      <sec>
         <st>
            <p>Introduction</p>
         </st>
         <p>We analyzed a database of 4367 patients (3519 male, 848 female) who underwent isolated coronary artery bypass graft (CABG) surgery at St George's Hospital between 1991 and 1998. We sought to identify pre-existing risk factors and postoperative complications among diabetic patients as opposed to nondiabetic patients that might explain the previously observed higher mortality among diabetic patients [<abbr bid="B1">1</abbr>].</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>Fourteen preoperative risk factors and nine postoperative outcome measures were analyzed by appropriate statistical tests, depending on whether the data were continuous or categorical.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>There were no significant differences between diabetic and nondiabetic persons with regard to age; New York Heart Association classification of heart failure; requirement for preoperative intra-aortic balloon pumping; left ventricular ejection fraction; incidence of myocardial infarction or requirement for percutaneous transluminal coronary angioplasty during the 30 days before surgery; or one-, two- or three-vessel disease or total cross-clamp time. However, time spent on cardiopulmonary bypass was longer in the diabetic group: 81.2 min versus 78.6 min in the nondiabetic group (two-tailed <it>P</it> &lt; 0.03). There were significant differences in pre-existing risk factors in diabetic persons versus nondiabetic persons: mean body mass index (27.3 kg/m<sup>2</sup> versus 26.6 kg/m<sup>2</sup>, respectively; <it>P</it> &lt; 0.00001), unstable angina (<it>n</it> = 251 versus <it>n</it> = 1244, respectively; <it>P</it> &lt; 0.004), hypertension (<it>n</it> = 302 versus <it>n</it> = 1278, respectively; <it>P</it> &lt; 0.000001) and renal failure requiring dialysis (<it>n</it> = 5 versus <it>n</it> = 8, respectively; <it>P</it> &lt; 0.01). These differences were reflected in a higher mean Parsonnet score (5.65 for diabetic persons versus 5.48 for nondiabetic persons; two-tailed <it>P</it> &lt; 0.0052).</p>
         <p>In-hospital mortality was significantly higher in the diabetic group (<it>n</it> = 31 [4.83%]) than in the nondiabetic group (<it>n</it> = 115 [3.09%]; <it>P</it> &lt; 0.02), a difference of 1.74%. In addition the diabetic group required a longer mean intensive care unit stay (2.06 days versus 1.76 days in the nondiabetic group; two-tailed <it>P</it> &lt; 0.0001). Diabetic persons were at increased risk for requiring postoperative haemofiltration (<it>P</it> &lt; 0.001), resuturing (<it>P</it> &lt; 0.04), and post-CABG laparotomy (<it>P</it> &lt; 0.002). There were no differences in requirement for postoperative intra-aortic balloon pumping, resternotomy rate, incidence of cerebrovascular accident, or requirement for tracheostomy.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p>There is a significantly greater postoperative morbidity and mortality among diabetic patients undergoing CABG surgery when compared with nondiabetic patients.</p>
      </sec>
   </bdy>
   <bm>
      <refgrp>
         <bibl id="B1">
            <title>
               <p>Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting.</p>
            </title>
            <aug>
               <au>
                  <snm>Herlitz</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Wognsen</snm>
                  <fnm>GB</fnm>
               </au>
               <au>
                  <snm>Emanuelsson</snm>
                  <fnm>H</fnm>
               </au>
               <au>
                  <snm>Haglid</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Karlson</snm>
                  <fnm>BW</fnm>
               </au>
               <au>
                  <snm>Karlsson</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Albertsson</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Westberg</snm>
                  <fnm>S</fnm>
               </au>
            </aug>
            <source>Diabetes Care</source>
            <pubdate>1996</pubdate>
            <volume>19</volume>
            <fpage>698</fpage>
            <lpage>703</lpage>
            <xrefbib>
               <pubid idtype="pmpid">8799622</pubid>
            </xrefbib>
         </bibl>
      </refgrp>
   </bm>
</art>
